These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20387990)

  • 41. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract].
    Zgoda MM; Nachajski MJ; Kołodziejczyk MK
    Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insensitivity of compaction properties of brittle granules to size enlargement by roller compaction.
    Wu SJ; Sun C
    J Pharm Sci; 2007 May; 96(5):1445-50. PubMed ID: 17455348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining experimental design and orthogonal projections to latent structures to study the influence of microcrystalline cellulose properties on roll compaction.
    Dumarey M; Wikström H; Fransson M; Sparén A; Tajarobi P; Josefson M; Trygg J
    Int J Pharm; 2011 Sep; 416(1):110-9. PubMed ID: 21708239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial moisture content in raw material can profoundly influence high shear wet granulation process.
    Shi L; Feng Y; Sun CC
    Int J Pharm; 2011 Sep; 416(1):43-8. PubMed ID: 21718767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A formulation strategy for solving the overgranulation problem in high shear wet granulation.
    Osei-Yeboah F; Zhang M; Feng Y; Sun CC
    J Pharm Sci; 2014 Aug; 103(8):2434-40. PubMed ID: 24985120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of binder droplet dimension on granulation rate during fluidized bed granulation.
    Fujiwara M; Dohi M; Otsuka T; Yamashita K; Sako K
    Chem Pharm Bull (Tokyo); 2013; 61(3):320-5. PubMed ID: 23449201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of binder in granules produced by means of twin screw granulation.
    Fonteyne M; Fussell AL; Vercruysse J; Vervaet C; Remon JP; Strachan C; Rades T; De Beer T
    Int J Pharm; 2014 Feb; 462(1-2):8-10. PubMed ID: 24361911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
    Abberger T
    Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coprocessing of cellulose II with amorphous silicon dioxide: effect of silicification on the powder and tableting properties.
    Rojas J; Kumar V
    Drug Dev Ind Pharm; 2012 Feb; 38(2):209-26. PubMed ID: 22088231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization of Premix Powders for Tableting Use.
    Todo H; Sato K; Takayama K; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2018 Jul; 66(7):748-756. PubMed ID: 29743471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of low shear, high shear, and fluid bed granulation during low dose tablet process development.
    Hausman DS
    Drug Dev Ind Pharm; 2004 Mar; 30(3):259-66. PubMed ID: 15109025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlations between micromeritic properties of mixing powders of danshen extract and formability of their pellets].
    Xtong ZW; Luo Y; Liao ZG; Zhao GW; Li Z; Luo J
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4317-23. PubMed ID: 25850259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development.
    Taylor MK; Ginsburg J; Hickey A; Gheyas F
    AAPS PharmSciTech; 2000 Jun; 1(3):E18. PubMed ID: 14727904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of polyvinylpyrrolidone, microcrystalline cellulose and colloidal silicon dioxide on technological characteristics of a high-dose Petiveria alliacea tablet.
    García-Pérez ME; Lemus-Rodríguez Z; Hung-Arbelo M; Vistel-Vigo M
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2011-2015. PubMed ID: 28762858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets.
    Fonteyne M; Wickström H; Peeters E; Vercruysse J; Ehlers H; Peters BH; Remon JP; Vervaet C; Ketolainen J; Sandler N; Rantanen J; Naelapää K; De Beer T
    Eur J Pharm Biopharm; 2014 Jul; 87(2):252-63. PubMed ID: 24589422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the mixing effectiveness of a new powder mixer.
    Palmieri GF; Lovato D; Marchitto L; Zanchetta A; Martelli S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):81-8. PubMed ID: 15605601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of a 2-step agglomeration process performed in a rotary processor using polyethylene glycol solutions as the primary binder liquid.
    Kristensen J
    AAPS PharmSciTech; 2006 Oct; 7(4):89. PubMed ID: 17233541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wet granulation in rotary processor and fluid bed: comparison of granule and tablet properties.
    Kristensen J; Hansen VW
    AAPS PharmSciTech; 2006 Mar; 7(1):E22. PubMed ID: 16584153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. To determine the end point of wet granulation by measuring powder energies and thermal properties.
    Dave RH; Wu SH; Contractor LD
    Drug Dev Ind Pharm; 2012 Apr; 38(4):439-46. PubMed ID: 22188039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of standard tablet formulation based on fluidized-bed granulation.
    Sunada H; Hasegawa M; Makino T; Sakamoto H; Fujita K; Tanino T; Kokubo H; Kawaguchi T
    Drug Dev Ind Pharm; 1998 Mar; 24(3):225-33. PubMed ID: 9876579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.